We are a science-driven wellness company pioneering innovative solutions and personalized approaches to health and well-being. We are building a new health category to deliver better health outcomes through a pro-active empowered approach. Our unique, vertically integrated brands, Thorne and Onegevity, provide actionable insights and personalized data, products and services that help individuals take a pro-active approach to improve and maintain their health over their lifetime. By combining our proprietary multi-omics database, artificial intelligence (AI) and digital health content with our science-backed nutritional supplements, we deliver a total system for wellness. We believe our integrated solution will redefine the expectations for good health and peak performance.

(Note: Thorne HealthTech priced its downsized IPO on Sept. 22, 2021, in line with the drastically reduced terms in its amended prospectus: 7 million shares at $10 – the bottom of its revised price range of $10 to $11 – to raise $70 million. Thorne HealthTech downsized its IPO in an S-1/A filing just hours ahead of pricing on Sept. 22, 2021: The deal was cut to 7 million shares, down from 9 million shares, and the price range was slashed to $10 to  $11, down from its initial price range of $13 to $15. The company now aims to raise $73.5 million, down from its initial projected proceeds of $126 million.)